Tectonic Therapeutics TECX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$74.15M-27.9% | -$57.98M-35.2% | -$42.88M+59.5% | -$105.89M+11.1% | ||
| $1.38M-16.4% | $1.65M+20.9% | $1.36M-4.4% | $1.42M+1.7% | ||
| $10.5M+201% | $3.49M— | —— | $11.52M-38.0% | ||
| -$60.08M-1.7% | -$59.08M-45.2% | -$40.68M+58.2% | -$97.21M+0.8% | ||
| —— | $156K-44.1% | $279K+4.5% | $267K-89.2% | ||
| -$138K+11.5% | -$156K+44.1% | -$279K-4.5% | -$267K+89.2% | ||
| —— | —— | $33.75M+12,781% | $262K-99.1% | ||
| —— | —— | —— | -$97.21M-38.6% | ||
| -$60.29M-1.8% | -$59.24M-44.6% | -$40.96M+58.0% | -$97.48M+3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tectonic Therapeutics generate?
- Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.
- What is Tectonic Therapeutics's free cash flow?
- After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.
- Where does Tectonic Therapeutics's cash flow data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.